Exploring SGLT-2 inhibitors and sarcopenia in FAERS: a post-marketing surveillance study
Our study identified potential new musculoskeletal and connective tissue disorder-related AE signals associated with SGLT-2 inhibitors.
Authors
- Lihong Gao (ORCID: https://orcid.org/0000-0002-8744-1436)
- Yangli Ye (ORCID: https://orcid.org/0000-0003-1875-3863)
- Zheng Kuai (ORCID: https://orcid.org/0000-0003-1866-5564)
- Guowen Tang
- Jie Yuan (ORCID: https://orcid.org/0009-0007-4538-5759)
- Xiaoyi Zhang (ORCID: https://orcid.org/0009-0004-9090-2100)
Institutions
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1080/14740338.2024.2412234
- Citations
- 4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- National Natural Science Foundation of China